Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EV/EBIT(x) 2.69-15.16-30.89-26.57

What is the latest EV/EBIT ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest EV/EBIT ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 2.69 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar20262.69
Mar2025-15.16
Mar2024-30.89
Mar2023-26.57

How is EV/EBIT of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years EV/EBIT % Change
Mar2026 2.69
Positive
Mar2025 -15.16
Negative
Mar2024 -30.89
Negative
Mar2023 -26.57 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare EV/EBIT ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,421.9 Cr 6.7% 0.6% 36.5% Stock Analytics
PRIME FOCUS ₹27,841.2 Cr 11.4% 20.4% 84.5% Stock Analytics
SAGILITY ₹21,304.7 Cr 1.3% 5% 2.7% Stock Analytics
SYNGENE INTERNATIONAL ₹15,246.6 Cr -0.6% -7.2% -41.4% Stock Analytics
INDEGENE ₹14,280.9 Cr 3.4% 4.3% 4% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹14,138.1 Cr 4% -3.9% -13.4% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

6.7%

0.6%

36.5%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses